ALAB

Astera Labs
D

ALAB

Arincen89/100B
221.790
USD
-6.10
(-2.68%)
Post Trading·216.770USD-5.020(-2.26%)
Last updated: · Delayed 15 min

Astera Labs income statement 2022–2026

1.56B USD over the last twelve months, and 852.53M USD in fiscal year 2025.

Revenue Operating income Net income

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
30 Sept 2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
Revenue
1.56B852.53M396.29M115.79M79.87M
Revenue growth
+115.24%+115.13%+242.24%+44.97%—
Cost of revenue
406.31M207.26M93.59M35.97M21.19M
Gross profit
1.15B645.26M302.70M79.83M58.68M
Gross margin
73.89%75.69%76.38%68.94%73.47%
Research and development
526.28M304.00M200.83M73.41M73.71M
Selling, general and administrative
226.56M167.84M217.94M35.92M45.16M
Operating expenses
752.84M471.84M418.77M109.32M118.88M
397.10M173.42M-116.07M-29.50M-60.19M
Operating income growth
+272.48%————
Operating margin
25.52%20.34%-29.29%-25.47%-75.36%
Interest income
50.09M44.73M34.29M6.55M2.61M
Other non-operating income
50.09M44.73M34.29M6.55M2.61M
Pretax income
447.18M218.15M-81.78M-22.95M-57.58M
Income tax
-14.14M-981.00K1.64M3.31M764.00K
Effective tax rate
-3.16%-0.45%———
461.32M219.13M-83.42M-26.26M-58.35M
Net income growth
+131.98%————
Net margin
29.64%25.70%-21.05%-22.68%-73.05%
Basic shares
171.48M166.41M131.26M152.50M130.45M
Diluted shares
182.17M179.55M131.26M152.50M130.45M
Change in diluted shares
+2.00%+36.79%-13.93%+16.90%—
EPS (basic)
2.681.32-0.64-0.17-0.45
EPS (diluted)
2.521.22-0.64-0.17-0.45
EPS growth
+127.03%————
EBITDA
444.70M224.98M-78.62M-21.17M-56.77M
EBITDA margin
28.57%26.39%-19.84%-18.28%-71.08%
EBIT
434.21M218.15M-81.78M-22.95M-57.58M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Common questions about Astera Labs's income statement

Source: Financial Modeling Prep